NO971538L - Purin- og guaninforbindelser som inhibitorer for PNP - Google Patents

Purin- og guaninforbindelser som inhibitorer for PNP

Info

Publication number
NO971538L
NO971538L NO971538A NO971538A NO971538L NO 971538 L NO971538 L NO 971538L NO 971538 A NO971538 A NO 971538A NO 971538 A NO971538 A NO 971538A NO 971538 L NO971538 L NO 971538L
Authority
NO
Norway
Prior art keywords
pnp
inhibitors
purine
guanine compounds
compounds
Prior art date
Application number
NO971538A
Other languages
English (en)
Norwegian (no)
Other versions
NO971538D0 (no
Inventor
Steven Collin Beasley
Alan Findlay Haughan
John Montana
Robert John Watson
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420093A external-priority patent/GB9420093D0/en
Priority claimed from GB9420045A external-priority patent/GB9420045D0/en
Priority claimed from GB9420127A external-priority patent/GB9420127D0/en
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of NO971538D0 publication Critical patent/NO971538D0/no
Publication of NO971538L publication Critical patent/NO971538L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO971538A 1994-10-05 1997-04-04 Purin- og guaninforbindelser som inhibitorer for PNP NO971538L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9420093A GB9420093D0 (en) 1994-10-05 1994-10-05 Compounds
GB9420045A GB9420045D0 (en) 1994-10-05 1994-10-05 Compounds
GB9420127A GB9420127D0 (en) 1994-10-05 1994-10-05 Compounds
PCT/GB1995/002363 WO1996011200A1 (fr) 1994-10-05 1995-10-05 Composes de purine et de guanine utilises comme inhibiteurs de pnp

Publications (2)

Publication Number Publication Date
NO971538D0 NO971538D0 (no) 1997-04-04
NO971538L true NO971538L (no) 1997-06-04

Family

ID=27267411

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971538A NO971538L (no) 1994-10-05 1997-04-04 Purin- og guaninforbindelser som inhibitorer for PNP

Country Status (14)

Country Link
US (1) US5736549A (fr)
EP (1) EP0784624A1 (fr)
JP (1) JPH10507171A (fr)
CN (1) CN1045088C (fr)
AU (1) AU695032B2 (fr)
BR (1) BR9509236A (fr)
CA (1) CA2201773A1 (fr)
CZ (1) CZ99797A3 (fr)
FI (1) FI971413A0 (fr)
HU (1) HUT77436A (fr)
MX (1) MX9702488A (fr)
NO (1) NO971538L (fr)
PL (1) PL319485A1 (fr)
WO (1) WO1996011200A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3047045B2 (ja) * 1994-10-22 2000-05-29 チョン クン ダン コーポレーション ヌクレオシド誘導体およびその製造方法
US7439359B2 (en) * 2000-11-02 2008-10-21 Sloan-Kettering Institute For Cancer Research Small molecule compositions for binding to hsp90
AU2003233667A1 (en) * 2002-05-23 2003-12-12 Biocryst Pharmaceuticals, Inc. Enhancing the efficacy of reverse transcriptase and dna polymerase inhibitors (nucleoside analogs) using pnp inhibitors and/or 2'-deoxyguanosine and/or prodrug thereof
US7553839B2 (en) * 2002-08-21 2009-06-30 Industrial Research Limited 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
WO2005053695A1 (fr) * 2003-12-04 2005-06-16 Eisai Co., Ltd. Agent preventif ou therapeutique de la sclerose en plaques
BRPI0509258A8 (pt) 2004-03-26 2019-01-22 Astrazeneca Ab composto de 8-oxoadenina 9-substituída
EP1768662A2 (fr) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
TW200801003A (en) * 2005-09-16 2008-01-01 Astrazeneca Ab Novel compounds
EP1939202A4 (fr) * 2005-09-22 2010-06-16 Dainippon Sumitomo Pharma Co Nouveau composé de l'adénine
JPWO2007034882A1 (ja) * 2005-09-22 2009-03-26 大日本住友製薬株式会社 新規アデニン化合物
EP1939200A4 (fr) * 2005-09-22 2010-06-16 Dainippon Sumitomo Pharma Co Nouveau composé adénine
TW200745114A (en) * 2005-09-22 2007-12-16 Astrazeneca Ab Novel compounds
JPWO2007034881A1 (ja) * 2005-09-22 2009-03-26 大日本住友製薬株式会社 新規アデニン化合物
US7700808B2 (en) 2005-12-26 2010-04-20 Nissan Chemical Industries, Ltd. 1-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
JP2009542645A (ja) * 2006-07-05 2009-12-03 アストラゼネカ・アクチエボラーグ Ｔｌｒ７のモジュレーターとして作用する８−オキソアデニン誘導体
TW200831105A (en) * 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
JP5329444B2 (ja) * 2007-03-19 2013-10-30 アストラゼネカ・アクチエボラーグ Ｔｏｌｌ様受容体（ｔｌｒ７）モジュレーターとしての９−置換−８−オキソ−アデニン化合物
EP2132209B8 (fr) * 2007-03-19 2014-04-16 AstraZeneca AB Composés 8-oxo-adenine 9 substitué comme modulateurs du récepteur de type toll (tlr7)
EP2138497A4 (fr) * 2007-03-20 2012-01-04 Dainippon Sumitomo Pharma Co Nouveau composé d'adénine
TW200902018A (en) * 2007-03-20 2009-01-16 Dainippon Sumitomo Pharma Co Novel adenine compound
BRPI0811125A2 (pt) 2007-05-08 2017-05-09 Astrazeneca Ab imidazoquinolinas com propriedades imunomoduladoras
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
UA104579C2 (uk) 2007-12-10 2014-02-25 Байокрист Фармасьютикалз, Инк. Спосіб лікування раку кровотворної системи із застосуванням фородезину у комбінації з ритуксимабом
UY31531A1 (es) 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
US8865896B2 (en) * 2008-01-17 2014-10-21 Astrazeneca Aktiebolag Method for preparing adenine compound
US20110054168A1 (en) * 2008-01-17 2011-03-03 Ayumu Kurimoto Method for preparing adenine compound
GB0908772D0 (en) * 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
AU2010250923A1 (en) 2009-05-21 2011-11-17 Astrazeneca Ab Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
JP2013512859A (ja) * 2009-12-03 2013-04-18 大日本住友製薬株式会社 トール様受容体（ｔｌｒ）を介して作用するイミダゾキノリン
CN103370317B (zh) 2010-12-16 2015-10-07 阿斯利康(瑞典)有限公司 可用于治疗的咪唑并[4,5-c]喹啉-1-基衍生物
WO2012080730A1 (fr) 2010-12-17 2012-06-21 Astrazeneca Ab Dérivés de purine
KR101708761B1 (ko) * 2012-04-13 2017-02-21 주식회사 머쉬메드 퓨린 유도체 또는 그의 염을 포함하는 아토피성 피부염의 예방 또는 치료용 조성물
CA2871589C (fr) 2012-05-18 2020-12-22 Seiji Hori Derives d'acide pyridine-2-carboxylique et leurs utilisations comme agonistes de tlr7

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI802401A7 (fi) * 1979-08-06 1981-01-01 Bristol Myers Co Keuhkoputkia laajentava puriini.
US4241063A (en) * 1979-08-06 1980-12-23 Bristol-Myers Company Purine derivatives and their use as bronchodilators
US4748177A (en) * 1984-03-26 1988-05-31 Warner-Lambert Company Guanine derivatives
EP0182024B1 (fr) * 1984-09-20 1991-04-03 Beecham Group Plc Dérivés de purine et leur utilisation pharmaceutique
IL76546A (en) * 1984-10-12 1988-12-30 Warner Lambert Co 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them
EP0193454A1 (fr) * 1985-02-25 1986-09-03 Merck & Co. Inc. Hydroxyalkyl- et hydroxyalkoxyméthyl-9 guanines substituées en position 8 et compositions pharmaceutiques les contenant
CA1293727C (fr) * 1986-08-26 1991-12-31 Catherine Rose Kostlan 9-deazaguanines
DE3855774T2 (de) * 1987-08-01 1997-06-12 Beecham Group Plc Purinverbindungen und ihre Herstellung
US4996308A (en) * 1988-03-25 1991-02-26 Merrell Dow Pharmaceuticals Inc. Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
WO1991006548A1 (fr) * 1989-10-31 1991-05-16 Biocryst, Inc. Inhibiteurs de phosphorylase de nucleoside de purine
US4985434A (en) * 1989-10-31 1991-01-15 Biocryst, Inc. 7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
NL9300058A (nl) * 1992-06-18 1994-01-17 Stichting Rega V Z W 1,5-anhydrohexitol nucleoside analoga en farmaceutisch gebruik daarvan.
US5314893A (en) * 1993-01-25 1994-05-24 Bristol-Myers Squibb Co. Antiviral tetrahydropyrans
WO1995022330A1 (fr) * 1994-02-17 1995-08-24 Commonwealth Scientific And Industrial Research Organisation Agents antiviraux

Also Published As

Publication number Publication date
CA2201773A1 (fr) 1996-04-18
US5736549A (en) 1998-04-07
FI971413L (fi) 1997-04-04
BR9509236A (pt) 1997-10-21
HUT77436A (hu) 1998-04-28
JPH10507171A (ja) 1998-07-14
CZ99797A3 (en) 1997-09-17
FI971413A7 (fi) 1997-04-04
FI971413A0 (fi) 1997-04-04
WO1996011200A1 (fr) 1996-04-18
AU695032B2 (en) 1998-08-06
MX9702488A (es) 1998-04-30
CN1045088C (zh) 1999-09-15
CN1160402A (zh) 1997-09-24
AU3612895A (en) 1996-05-02
EP0784624A1 (fr) 1997-07-23
PL319485A1 (en) 1997-08-04
NO971538D0 (no) 1997-04-04

Similar Documents

Publication Publication Date Title
MX9702488A (es) Compuestos de purina y guanina como inhibidores de pnp.
DE69618231D1 (de) TETRAHYDROIMIDAZOPYRIDOINDOLDIONE ALS cGMP SPEZIFISCHE PDE HEMMER
DK0582788T3 (da) 7-(Substituerede)-9-[(substitueret glycyl)-amido]-demethyl-6-deoxytetracycliner
MX9700557A (es) Dihidrobenzofuranos.
DK0766670T3 (da) Tri-substituerede phenylderivater anvendelige som PDE IV inhibitorer
NO931695L (no) Nye 4-arylpiperaciner og 4-arylpiperidiner
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
NO992821L (no) Ketobenzamider som calpain-inhibitorer
FI943856A7 (fi) Tri-substituoituja fenyylijohdannaisia fosfodiesteraasi-inhibiittoreina
IT1285770B1 (it) Composti corticoidei
EP0932606A4 (fr) Inhibiteurs de prenyl-transferases
ATE233252T1 (de) Substituierte dihydrobenzofurane als pde- hemmstoffe
NO933524D0 (no) Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav
AU3025689A (en) Substituted 1,2,4-triazinediones, processes for their preparation and their use
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
DK345588D0 (da) 1,2-diketo-derivater til anvendelse som renin-inhibitorer
NO954609L (no) Niopecotiske syrederivater som antitrombiske forbindelser
DK0579968T3 (da) 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
NO952427D0 (no) Metode for behandling av kronisk prostatitt med 17 substituerte karbamoyl-4-aza-5
ES2123728T3 (es) Derivados de pirrolo-pirazina de actividad 5-ht3.
NO972905L (no) Tienoksasinon-derivater anvendelige som antivirusmidler
ES2173634T3 (es) Compuestos heterociclicos que presentan actividad inhibidora de mmp y tnf.
GT199400074A (es) Pirroles substituidos
DK0937075T3 (da) Hidtil ukendte imidazo- og oxazolopyridiner som phosphodiesteraseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application